MERCK ANNOUNCES SALE OF POXEL EQUITY STAKE
(Thomson Reuters ONE) -
MERCK SANTÉ SAS /
MERCK ANNOUNCES SALE OF POXEL EQUITY STAKE
. Processed and transmitted by Nasdaq Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
Press Release
Your contact :
Merck
Constance de Quinsonas +33 6 40 87 79 54
constance.de-quinsonas(at)merckgroup.com
THIS PRESS RELEASE MAY NOT BE DISSEMINATED, DIRECTLY OR INDIRECTLY, IN THE
UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN.
MERCK ANNOUNCES SALE OF POXEL EQUITY STAKE
Darmstadt, Allemagne, 6 october 2017 - Merck Santé SAS, an affiliate of Merck
KGaA, today announces it sold its entire 4.74 percent stake of 1,088,531 shares
in Poxel SA through sales on the market.
Merck reaffirms its full support to Poxel's strategy. The divestment of Merck's
equity stake in Poxel was driven by Merck's period reassessment of strategic
priorities. Merck will retain its economic interest in Poxel's activities
through royalties derived from their existing license agreement.
* * *
This announcement is for information purposes only and does not constitute an
offer to sell or the solicitation of an offer to buy any securities in any
jurisdiction, including France and other member states of the European Economic
Area.
The sale of Poxel shares referred to in this announcement has not been, nor will
be, registered under the United States Securities Act of 1933 (the "Securities
Act").
Release, publication or distribution of this press release is forbidden in any
country where it would violate applicable laws or regulations.
This press release is not to be published, transmitted or distributed, directly
or indirectly, in the United States of America, Australia, Canada or Japan.
About Merck
Merck is a leading science and technology company in healthcare, life science
and performance materials. Around 50,000 employees work to further develop
technologies that improve and enhance life - from biopharmaceutical therapies to
treat cancer or multiple sclerosis, cutting-edge systems for scientific research
and production, to liquid crystals for smartphones and LCD televisions. In
2015, Merck generated sales of ? 12.85 billion in 66 countries.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical
company. The founding family remains the majority owner of the publicly listed
corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck
name and brand. The only exceptions are the United States and Canada, where the
company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
Press release (PDF):
http://hugin.info/174678/R/2140254/819548.pdf
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: MERCK SANTÉ SAS via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 06.10.2017 - 18:24 Uhr
Sprache: Deutsch
News-ID 562767
Anzahl Zeichen: 3666
contact information:
Town:
Lyon
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 312 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"MERCK ANNOUNCES SALE OF POXEL EQUITY STAKE"
steht unter der journalistisch-redaktionellen Verantwortung von
MERCK SANTÉ SAS (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
